AZD-3514
An investigational drug for prostate cancer
AZD-3514 is an investigational drug that has been studied for its potential use in the treatment of prostate cancer. It is a selective androgen receptor modulator (SARM) that works by inhibiting the androgen receptor signaling pathway, which is crucial for the growth and survival of prostate cancer cells.
Mechanism of Action[edit | edit source]
AZD-3514 functions by binding to the androgen receptor (AR) and inhibiting its activity. The androgen receptor is a type of nuclear receptor that is activated by binding to androgens, such as testosterone and dihydrotestosterone (DHT). In prostate cancer, the AR signaling pathway is often upregulated, leading to increased tumor growth and progression. By inhibiting AR signaling, AZD-3514 aims to reduce the proliferation of cancer cells and induce apoptosis.
Clinical Development[edit | edit source]
AZD-3514 has undergone several phases of clinical trials to evaluate its safety, efficacy, and pharmacokinetics in patients with advanced prostate cancer. Early-phase trials have shown that AZD-3514 can effectively reduce prostate-specific antigen (PSA) levels, a marker used to monitor prostate cancer progression. However, further studies are needed to fully establish its clinical benefits and potential side effects.
Pharmacokinetics[edit | edit source]
The pharmacokinetic profile of AZD-3514 includes its absorption, distribution, metabolism, and excretion (ADME) characteristics. AZD-3514 is administered orally and is absorbed into the bloodstream, where it is distributed to various tissues, including the prostate. It is metabolized primarily in the liver and excreted through the kidneys.
Potential Side Effects[edit | edit source]
As with many investigational drugs, AZD-3514 may have side effects. Commonly reported adverse effects include fatigue, nausea, and changes in liver function tests. It is important for patients to be monitored regularly during treatment to manage any potential side effects.
Research and Future Directions[edit | edit source]
Research on AZD-3514 is ongoing, with studies focusing on optimizing its therapeutic efficacy and minimizing side effects. Combination therapies with other anti-cancer agents are also being explored to enhance treatment outcomes for patients with prostate cancer.
Also see[edit | edit source]
- Prostate cancer
- Androgen receptor
- Selective androgen receptor modulator
- Hormone therapy for prostate cancer
Template:Prostate cancer drugs
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
